Picture of Achilles Therapeutics logo

ACHL — Achilles Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Brief: Achilles Therapeutics Reports Third Quarter 2021 Financial Results And Recent Business Highlights

Nov 9 (Reuters) - Achilles Therapeutics PLC  698y.F :
    * ACHILLES THERAPEUTICS REPORTS THIRD QUARTER 2021 FINANCIAL
RESULTS AND RECENT BUSINESS HIGHLIGHTS
    * ACHILLES THERAPEUTICS REPORTS THIRD QUARTER 2021 FINANCIAL
RESULTS AND RECENT BUSINESS HIGHLIGHTS
    * QTRLY NET LOSS PER SHARE ATTRIBUTABLE TO ORDINARY
SHAREHOLDERS
BASIC AND DILUTED $0.34
    * ANTICIPATES CASH AND CASH EQUIVALENTS ARE SUFFICIENT TO
FUND
PLANNED OPERATIONS INTO SECOND HALF OF 2023
    * Q3 EARNINGS PER SHARE VIEW $-0.48 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX9FF2hR 
Further company coverage:  698Y.F 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Achilles Therapeutics

See all news